Anastasi E - Search Results

1

HE4: a new potential early biomarker for the recurrence of ovarian cancer.

Anastasi E, Marchei GG, Viggiani V, Gennarini G, Frati L, Reale MG. Anastasi E, et al. Tumour Biol. 2010 Apr;31(2):113-9. doi: 10.1007/s13277-009-0015-y. Epub 2010 Jan 23. Tumour Biol. 2010. PMID: 20358424

2

Impact of SARS-CoV-2 vaccination on FcγRIIIA/CD16 dynamics in Natural Killer cells: relevance for antibody-dependent functions.

Capuano C, De Federicis D, Ciuti D, Turriziani O, Angeloni A, Anastasi E, Giannini G, Belardinilli F, Molfetta R, Alvaro D, Palmieri G, Galandrini R. Capuano C, et al. Among authors: anastasi e. Front Immunol. 2023 Nov 16;14:1285203. doi: 10.3389/fimmu.2023.1285203. eCollection 2023. Front Immunol. 2023. PMID: 38045702 Free PMC article.

3

Expression of activated Notch3 in transgenic mice enhances generation of T regulatory cells and protects against experimental autoimmune diabetes.

Anastasi E, Campese AF, Bellavia D, Bulotta A, Balestri A, Pascucci M, Checquolo S, Gradini R, Lendahl U, Frati L, Gulino A, Di Mario U, Screpanti I. Anastasi E, et al. J Immunol. 2003 Nov 1;171(9):4504-11. doi: 10.4049/jimmunol.171.9.4504. J Immunol. 2003. PMID: 14568923

4

Notch3 and pTalpha/pre-TCR sustain the in vivo function of naturally occurring regulatory T cells.

Campese AF, Grazioli P, Colantoni S, Anastasi E, Mecarozzi M, Checquolo S, De Luca G, Bellavia D, Frati L, Gulino A, Screpanti I. Campese AF, et al. Among authors: anastasi e. Int Immunol. 2009 Jun;21(6):727-43. doi: 10.1093/intimm/dxp042. Epub 2009 May 21. Int Immunol. 2009. PMID: 19461123

5

Ovarian tumor marker HE4 is differently expressed during the phases of the menstrual cycle in healthy young women.

Anastasi E, Granato T, Marchei GG, Viggiani V, Colaprisca B, Comploj S, Reale MG, Frati L, Midulla C. Anastasi E, et al. Tumour Biol. 2010 Oct;31(5):411-5. doi: 10.1007/s13277-010-0049-1. Epub 2010 May 20. Tumour Biol. 2010. PMID: 20490961

6

HE4 in the differential diagnosis of a pelvic mass: a case report.

Anastasi E, Granato T, Coppa A, Manganaro L, Giannini G, Comploj S, Frati L, Midulla C. Anastasi E, et al. Int J Mol Sci. 2011 Jan 18;12(1):627-32. doi: 10.3390/ijms12010627. Int J Mol Sci. 2011. PMID: 21340004 Free PMC article.

7

HE4 combined with MDCT imaging is a good marker in the evaluation of disease extension in advanced epithelial ovarian carcinoma.

Midulla C, Manganaro L, Longo F, Viggiani V, Frati L, Granato T, Anastasi E. Midulla C, et al. Among authors: anastasi e. Tumour Biol. 2012 Oct;33(5):1291-8. doi: 10.1007/s13277-012-0376-5. Epub 2012 Mar 20. Tumour Biol. 2012. PMID: 22430259

8

Role of HE4, CA72.4, and CA125 in monitoring ovarian cancer.

Granato T, Midulla C, Longo F, Colaprisca B, Frati L, Anastasi E. Granato T, et al. Among authors: anastasi e. Tumour Biol. 2012 Oct;33(5):1335-9. doi: 10.1007/s13277-012-0381-8. Epub 2012 Apr 13. Tumour Biol. 2012. PMID: 22528938

9

CLEIA CA125 evidences: good analytical performance avoiding "Hook effect".

Falzarano R, Viggiani V, Michienzi S, Colaprisca B, Longo F, Frati L, Anastasi E. Falzarano R, et al. Among authors: anastasi e. Tumour Biol. 2013 Feb;34(1):387-93. doi: 10.1007/s13277-012-0561-6. Epub 2012 Nov 1. Tumour Biol. 2013. PMID: 23111756

10

Evaluation of a CLEIA automated assay system for the detection of a panel of tumor markers.

Falzarano R, Viggiani V, Michienzi S, Longo F, Tudini S, Frati L, Anastasi E. Falzarano R, et al. Among authors: anastasi e. Tumour Biol. 2013 Oct;34(5):3093-100. doi: 10.1007/s13277-013-0877-x. Epub 2013 Jun 18. Tumour Biol. 2013. PMID: 23775009

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

131 results

Search Page

Filters